DRISCOLL FREDERICK W

CEO/PRESIDENT at GENELABS TECHNOLOGIES INC /CA · on record since Sep 3, 2008
Director at GOLDRICH MINING CO · on record since Nov 18, 2025
CEO at SOUTHWALL TECHNOLOGIES INC /DE/ · on record since Jan 7, 2009
VP, CFO & Treasurer at NOVAVAX INC · on record since Aug 25, 2009
Chief Financial Officer at Flexion Therapeutics Inc · on record since Feb 11, 2014
Director at Oncotelic Therapeutics, Inc. · on record since Jan 6, 2014
President and CEO at Oncotelic Therapeutics, Inc. · on record since Feb 17, 2004
Director at Cellectar Biosciences, Inc. · on record since Apr 18, 2017
Director at ImmunityBio, Inc. · on record since Sep 20, 2017
Director at Lite Strategy, Inc. · on record since Feb 26, 2018
Director at Cue Biopharma, Inc. · on record since Jun 27, 2018
Director at ABRAXAS PETROLEUM CORP · on record since May 10, 2018
INTERIM CFO & INTERIM TREAS at Conformis Inc · on record since Oct 28, 2019
Chief Financial Officer at Renovacor, Inc. · on record since Mar 28, 2022
Interim CFO at Invivyd, Inc. · on record since Oct 13, 2022

Insider trading activity of DRISCOLL FREDERICK W

Transactions on record: 86; since Feb 17, 2004

Open-market buys: 7; $216.1K

Open-market sells: 7; $1.5M

Companies traded: 11; last filing Jul 8, 2026

Figures computed from official regulatory filings — .

Companies where DRISCOLL FREDERICK W has traded

Cellectar Biosciences, Inc.11 tx · $20.2K · Jul 8, 2026
1 tx · Nov 18, 2025
10 tx · $200.8K · Jul 17, 2025
8 tx · Jan 3, 2025
1 tx · Mar 28, 2022
22 tx · $1.4M · Nov 19, 2021
7 tx · $667.9K · Aug 13, 2020
10 tx · $14.6K · Jun 3, 2016
8 tx · $865.1K · Mar 6, 2013
7 tx · $495.5K · Jan 7, 2009
1 tx · $299K · Jan 7, 2009

Track record of DRISCOLL FREDERICK W

Statistical track record

Free account

Open-market buys: 7

Last buy: Sep 3, 2021

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of DRISCOLL FREDERICK W

Co-insiders of DRISCOLL FREDERICK W

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Cellectar Biosciences, Inc.Listing on record	Jul 8, 2026	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GOLDRICH MINING COListing on record	Nov 18, 2025	AwardD (derivative)	55,000	—	n/a (No price was disclosed in the filing)		SEC
Lite Strategy, Inc.Listing unverified	Jul 17, 2025	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cellectar Biosciences, Inc.Listing on record	Feb 18, 2025	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cue Biopharma, Inc.Listing on record	Jan 3, 2025	AwardD (derivative)	24,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cellectar Biosciences, Inc.Listing on record	Jun 18, 2024	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cue Biopharma, Inc.Listing on record	Jan 4, 2024	AwardD (derivative)	24,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lite Strategy, Inc.Listing unverified	Oct 12, 2023	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cellectar Biosciences, Inc.Listing on record	Jun 28, 2023	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cue Biopharma, Inc.Listing on record	Jan 5, 2023	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cellectar Biosciences, Inc.Listing on record	Aug 1, 2022	AwardD (derivative)	7,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lite Strategy, Inc.Listing unverified	Jul 7, 2022	AwardD (derivative)	87.5	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Renovacor, Inc.Listing unverified	Mar 28, 2022	AwardD (derivative)	155,325	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cue Biopharma, Inc.Listing on record	Jan 5, 2022	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Flexion Therapeutics IncListing unverified	Nov 19, 2021	OtherD (derivative)	-168,000	—	n/a (No price was disclosed in the filing)		SEC
Flexion Therapeutics IncListing unverified	Nov 19, 2021	Other	-30,680	8.50 USD	$260.8K	Unusual size	SEC
Cellectar Biosciences, Inc.Listing on record	Sep 7, 2021	Buy	19,417	1.04 USD	$20.2K	conv 44First in 12mo	SEC
Lite Strategy, Inc.Listing unverified	Jul 6, 2021	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cellectar Biosciences, Inc.Listing on record	Jul 2, 2021	AwardD (derivative)	78,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Flexion Therapeutics IncListing unverified	Jun 3, 2021	AwardD (derivative)	168,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Flexion Therapeutics IncListing unverified	Jun 3, 2021	Award	28,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lite Strategy, Inc.Listing unverified	Feb 24, 2021	Sell	-25,000	4.03 USD	$100.8K		SEC
Cue Biopharma, Inc.Listing on record	Jan 6, 2021	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ImmunityBio, Inc.Listing on record	Aug 13, 2020	Sell	-5,300	10.77 USD	$57.1K		SEC
ImmunityBio, Inc.Listing on record	Aug 13, 2020	Sell	-10,000	9.98 USD	$99.8K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Cellectar Biosciences, Inc.Listing on record	Jul 8, 2026	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GOLDRICH MINING COListing on record	Nov 18, 2025	AwardD (derivative)	55,000	—	n/a (No price was disclosed in the filing)		SEC
Lite Strategy, Inc.Listing unverified	Jul 17, 2025	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cellectar Biosciences, Inc.Listing on record	Feb 18, 2025	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cue Biopharma, Inc.Listing on record	Jan 3, 2025	AwardD (derivative)	24,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cellectar Biosciences, Inc.Listing on record	Jun 18, 2024	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cue Biopharma, Inc.Listing on record	Jan 4, 2024	AwardD (derivative)	24,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lite Strategy, Inc.Listing unverified	Oct 12, 2023	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cellectar Biosciences, Inc.Listing on record	Jun 28, 2023	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cue Biopharma, Inc.Listing on record	Jan 5, 2023	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cellectar Biosciences, Inc.Listing on record	Aug 1, 2022	AwardD (derivative)	7,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lite Strategy, Inc.Listing unverified	Jul 7, 2022	AwardD (derivative)	87.5	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Renovacor, Inc.Listing unverified	Mar 28, 2022	AwardD (derivative)	155,325	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cue Biopharma, Inc.Listing on record	Jan 5, 2022	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Flexion Therapeutics IncListing unverified	Nov 19, 2021	OtherD (derivative)	-168,000	—	n/a (No price was disclosed in the filing)		SEC
Flexion Therapeutics IncListing unverified	Nov 19, 2021	Other	-30,680	8.50 USD	$260.8K	Unusual size	SEC
Cellectar Biosciences, Inc.Listing on record	Sep 7, 2021	Buy	19,417	1.04 USD	$20.2K	conv 44First in 12mo	SEC
Lite Strategy, Inc.Listing unverified	Jul 6, 2021	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cellectar Biosciences, Inc.Listing on record	Jul 2, 2021	AwardD (derivative)	78,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Flexion Therapeutics IncListing unverified	Jun 3, 2021	AwardD (derivative)	168,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Flexion Therapeutics IncListing unverified	Jun 3, 2021	Award	28,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lite Strategy, Inc.Listing unverified	Feb 24, 2021	Sell	-25,000	4.03 USD	$100.8K		SEC
Cue Biopharma, Inc.Listing on record	Jan 6, 2021	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ImmunityBio, Inc.Listing on record	Aug 13, 2020	Sell	-5,300	10.77 USD	$57.1K		SEC
ImmunityBio, Inc.Listing on record	Aug 13, 2020	Sell	-10,000	9.98 USD	$99.8K		SEC